Search Results 1101-1110 of 18109 for Hepatitis b

  1. Vaccine Research Group: Gregory A. Poland, Richard B. Kennedy, Inna G. Ovsyannikova

    The Vaccine Research Group at Mayo Clinic, led by Dr. Poland, Dr. Kennedy and Dr. Ovsyannikova, researches vaccines, immunity and the threat of infectious ...

  2. A study to test whether survodutide helps people with a liver disease called NASH/MASH who have cirrhosis - Mayo Clinic

    ... hepatitis or overlap syndrome, Wilson's disease, alpha-1-antitrypsin deficiency, or genetic haemochromatosis. Hepatitis B positive (defined as positive HBsAg) ...

  3. A Study to Evaluate the Impact on NASH with Fibrosis of Obeticholic Acid Treatment - Mayo Clinic

    Participation eligibility · Positive test result at Screening for hepatitis B surface antigen (hBsAg); · Active hepatitis C virus (HCV) infection (positive for ...

  4. Publications - Amanda B. Ebright, M.D. - Mayo Clinic

    Kasten MJ, Berman AC, Ebright AB, Mitchell JD, Quirindongo-Cedeno O. Interpreters in Health Care: A Concise Review for Clinicians. Am J Med.

  5. Overview - Vaccines: Gregory A. Poland, Richard B. Kennedy - Mayo Clinic Research

    The Vaccine Research Group at Mayo Clinic, led by Dr. Poland, Dr. Kennedy and Dr. Ovsyannikova, researches vaccines, immunity and the threat of infectious ...

  6. Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch - Mayo Clinic

    * Known HIV or active Hepatitis B/C * Clinically significant liver disease (Primary Sclerosing Cholangitis with LFT's \<1.5 upper limit of normal can be ...

  7. A Study of JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/​r B-NHL) - Mayo Clinic

    The goal of this multicenter study is to test JNJ-90009530 in Relapsed or Refractory Non-Hodgkin Lymphoma Patients. The main questions the study aims to answer ...

  8. VSV-hIFNbeta-NIS in Treating Patients With Stage IV or Recurrent Endometrial Cancer - Mayo Clinic

    NOTE: Group B patients have no maximum tumor size. The following laboratory ... History of hepatitis B or C or chronic hepatitis. Other concurrent ...

  9. Membrane Trafficking in Disease - Research Team

    McNiven. Sections. Overview · Research Team; Focus Areas Focus Areas. Lipid Droplet Biology and Fatty Liver · Mechanisms of Hepatitis B Infection · Tumor Cell ...

  10. A Study of Adjuvant Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab for Resected High-Risk Melanoma in Participants With High-Risk Stage II-IV Melanoma (MK-7684A-010/KEYVIBE-010) - Mayo Clinic

    on anti-retroviral therapy (ART). - Participants who are hepatitis B surface antigen (HBsAg) positive are eligible if they have received hepatitis B virus (HBV) ...